Clinical Trial: Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)

Brief Summary: ReWalk suit developed by Argo Medical Technologies is designed to enable people with lower limb disabilities to carry out routine ambulatory functions (stand, walk etc.); it can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other pathologies that produce severe walking impairments.

Detailed Summary:
Sponsor: ReWalk Robotics, Inc.

Current Primary Outcome: Safety of use [ Time Frame: 3 months ]

Number of participants with related adverse events as a Measure of Safety and Tolerability


Original Primary Outcome: Same as current

Current Secondary Outcome: Efficacy [ Time Frame: 3 months ]

Continuously walking for 6 minutes after 18 sessions training with the ReWalk - exoskeleton suit performed at weekly intervals


Original Secondary Outcome: Same as current

Information By: ReWalk Robotics, Inc.

Dates:
Date Received: November 28, 2010
Date Started: March 2009
Date Completion:
Last Updated: October 4, 2016
Last Verified: October 2016